Neuralgia Treatment Global Market Report 2024

Neuralgia Treatment Global Market Report 2024 – By Treatment (Drug Based, Surgeries), By Indication (Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia), By Distribution channels (Drug Stores, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Use (Hospitals And Clinics, Ambulatory Surgery Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Neuralgia Treatment Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Neuralgia Treatment Market Definition And Segments

Neuralgia treatment refers to treating a medical condition characterized by chronic pain that affects the nerves and can be caused by injury, infection, or underlying medical conditions. Neuralgia treatment is used to manage symptoms, slow the progression of the Neuralgia and prevent complications.

The main types of neuralgia treatments included are drug-based and surgeries. Drug-based treatment refers to the treatment through the use of drugs or medications to manage, alleviate, or cure various medical conditions and diseases. Various types of indications are involved, such as diabetic neuropathy, intercostal neuralgia, occipital neuralgia, peripheral neuralgia and postherpetic neuralgia. It is sold through several distribution channels, including drug stores, hospital pharmacies, online pharmacies and retail pharmacies and is used for various end-uses, such as hospitals and clinics, ambulatory surgery centers and others.

The neuralgia treatment market covered in this report is segmented –

1) By Treatment: Drug Based, Surgeries

2) By Indication: Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia

3) By Distribution channels: Drug Stores, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

4) By End-Use: Hospitals And Clinics, Ambulatory Surgery Centers, Other End-Users

The neuralgia treatment market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.3 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising prevalence of neuralgia, neuropathic pain awareness, rise in chronic pain conditions, presence of high disposable income, government initiatives.

The neuralgia treatment market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to aging population, emerging therapies, increasing incidences of diabetes, high healthcare expenditure. Major trends in the forecast period include advancements in pain management, innovative products, digital health integration, development of new drug delivery systems.

Growing Prevalence Of Chronic Diseases, Including Diabetes, Fuels Growth In The Neuralgia Treatment Market

The rising prevalence of chronic diseases, such as diabetes, is expected to propel the growth of the neuralgia treatment market going forward. Chronic diseases are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Diabetes is a long-term metabolic condition characterized by high blood glucose, also called blood sugar. Neuralgia treatment can treat diabetic neuropathy, the nerve damage that can occur in people with diabetes. For instance, in December 2021, according to the International Diabetes Federation, a US-based intergovernmental organization, diabetes affected 537 million adults (20–79 years old) in 2021 and it is predicted that the number will increase to 643 million people by 2030 and a total of 783 million by 2045. Therefore, the rising prevalence of chronic diseases, such as diabetes, is driving the growth of the neuralgia treatment market.

Expanding Horizons For The Neuralgia Treatment Market Driven By Anticipated Surge In Surgical Procedures

The anticipated increase in the volume of surgical procedures is expected to drive the expansion of the neuralgia treatment market in the future. Surgical procedures refer to medical interventions or treatments that involve making incisions or using minimally invasive techniques to access and manipulate tissues or organs within the body. Surgical procedures can play a role in fueling the growth of neuralgia treatment by offering options for cases where non-surgical treatments have not been effective or when there's a specific anatomical cause that can be addressed surgically. For instance, in April 2022, according to the Aesthetic Society, a US-based industry organization of plastic surgeons, Surgical aesthetic procedures saw a 54% rise in 2021 compared to 2020. On average, surgeons conducted 320 procedures in 2021, marking an increase from 220 procedures in 2020. Hence, the growth of the neuralgia treatment market is being propelled by a rising number of surgical procedures.

Major players in the neuralgia treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Horizon Therapeutics, Purdue Pharma, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals, Glenmark Pharmaceuticals, Tonix Pharmaceuticals.

High Cost Of Treatment Can Impact The Neuralgia Treatment Market Growth

The cost of neuralgia treatment can be high, which can limit access to treatment and impact market growth. The high cost of treatment can significantly impede the growth of the neuralgia treatment market by less affordability of effective treatments and reducing overall market demand. Additionally, the high cost of treatment can be a barrier for some patients, particularly in developing countries. For instance, in September 2022, as per the study published in the Journal of Headache and Pain, a Germany-based reviewed open access journal, evaluated the long-term outcomes of a multidisciplinary trigeminal neuralgia service. The study found that the cost of treatment for trigeminal neuralgia can be high, with patients requiring multiple medications and procedures throughout their treatment. Therefore, the high cost of neuralgia treatment treatment is hindering the growth of the neuralgia treatment market.

Innovative Products Drive Market Advancements In The Neuralgia Treatment Industry

Major companies operating in the neuralgia treatment market are focused on developing innovative products and solutions to sustain their position in the market. For instance, in April 2023, in India, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Shingrix, the world's first non-live and recombinant subunit vaccine. This vaccine is designed to prevent shingles and post-herpetic neuralgia in adults aged 50 years and older and is administered intramuscularly in two doses. Shingrix combines the antigen glycoprotein E with the adjuvant system AS01B to produce a potent and long-lasting immunological response that can help counteract the immune system's deterioration with age. Clinical trials have shown that it is 97% effective in preventing shingles in adults. It also effectively prevents post-herpetic neuralgia, a painful complication of shingles.

Kriya Therapeutics Enhances Gene Therapy Portfolio With Acquisition Of Redpin Therapeutics

In November 2022, Kriya Therapeutics Inc., a US-based gene therapy company, acquired Redpin Therapeutics Inc. for an undisclosed amount. The acquisition will help Kriya Therapeutics Inc. strengthen its gene therapy offering for neurological disorders, including epilepsy, trigeminal neuralgia and Parkinson's disease. Redpin Therapeutics Inc. is a US-based biotechnology company that effectively treats various neurological disorders, including neuralgia.

North America was the largest region in the neuralgia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuralgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuralgia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuralgia treatment market consists of revenues earned by entities by providing blood tests, magnetic resonance imaging (MRI), nerve conduction velocity tests, physical therapies and alternative therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuralgia treatment market also includes sales of anticonvulsant medications, pain relievers, antidepressants and antiseizure medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The neuralgia treatment market research report is one of a series of new reports from The Business Research Company that provides neuralgia treatment market statistics, including neuralgia treatment industry global market size, regional shares, competitors with a neuralgia treatment market share, detailed neuralgia treatment market segments, market trends and opportunities and any further data you may need to thrive in the neuralgia treatment industry. This neuralgia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neuralgia Treatment Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.3 billion
Revenue Forecast In 2033 $2.92 billion
Growth Rate CAGR of 6.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment: Drug Based, Surgeries
2) By Indication: Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia
3) By Distribution channels: Drug Stores, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Use: Hospitals And Clinics, Ambulatory Surgery Centers, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Eli Lilly and Company; Gilead Sciences Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Astellas Pharma Inc.; Biogen Inc.; Daiichi Sankyo Company Limited; Boehringer Ingelheim International GmbH; Sun Pharmaceutical Industries Limited; Horizon Therapeutics; Purdue Pharma; Dr. Reddy's Laboratories; Cipla Limited; Hikma Pharmaceuticals plc; Zydus Lifesciences Ltd.; Lupin Limited; Mallinckrodt Pharmaceuticals; Glenmark Pharmaceuticals; Tonix Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Neuralgia Treatment Market Characteristics

    3. Neuralgia Treatment Market Trends And Strategies

    4. Neuralgia Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Neuralgia Treatment Market Size and Growth

    5.1. Global Neuralgia Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Neuralgia Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Neuralgia Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Neuralgia Treatment Market Segmentation

    6.1. Global Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Drug Based

    Surgeries

    6.2. Global Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Diabetic Neuropathy  

    Intercostal Neuralgia

    Occipital Neuralgia

    Peripheral Neuralgia

    Postherpetic Neuralgia

    6.3. Global Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Drug Stores

    Hospital Pharmacies

    Online Pharmacies

    Retail Pharmacies

    6.4. Global Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Clinics

    Ambulatory Surgery Centers

    Other End-Users

    7. Neuralgia Treatment Market Regional And Country Analysis

    7.1. Global Neuralgia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Neuralgia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Neuralgia Treatment Market  

    8.1. Asia-Pacific Neuralgia Treatment Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Neuralgia Treatment Market  

    9.1. China Neuralgia Treatment Market Overview  

    9.2. China Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Neuralgia Treatment Market  

    10.1. India Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Neuralgia Treatment Market  

    11.1. Japan Neuralgia Treatment Market Overview  

    11.2. Japan Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Neuralgia Treatment Market  

    12.1. Australia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Neuralgia Treatment Market  

    13.1. Indonesia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Neuralgia Treatment Market  

    14.1. South Korea Neuralgia Treatment Market Overview  

    14.2. South Korea Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Neuralgia Treatment Market  

    15.1. Western Europe Neuralgia Treatment Market Overview

    15.2. Western Europe Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Neuralgia Treatment Market  

    16.1. UK Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Neuralgia Treatment Market  

    17.1. Germany Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Neuralgia Treatment Market  

    18.5. France Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Neuralgia Treatment Market  

    19.9. Italy Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Neuralgia Treatment Market  

    20.13. Spain Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Neuralgia Treatment Market  

    21.1. Eastern Europe Neuralgia Treatment Market Overview

    21.2. Eastern Europe Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Neuralgia Treatment Market  

    22.1. Russia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Neuralgia Treatment Market  

    23.1. North America Neuralgia Treatment Market Overview

    23.2. North America Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Neuralgia Treatment Market  

    24.1. USA Neuralgia Treatment Market Overview

    24.2. USA Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Neuralgia Treatment Market  

    25.1. Canada Neuralgia Treatment Market Overview

    25.2. Canada Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Neuralgia Treatment Market  

    26.1. South America Neuralgia Treatment Market Overview

    26.2. South America Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Neuralgia Treatment Market  

    27.1. Brazil Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Neuralgia Treatment Market  

    28.1. Middle East Neuralgia Treatment Market Overview

    28.2. Middle East Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Neuralgia Treatment Market  

    29.1. Africa Neuralgia Treatment Market Overview

    29.2. Africa Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Neuralgia Treatment Market Competitive Landscape And Company Profiles

    30.1. Neuralgia Treatment Market Competitive Landscape

    30.2. Neuralgia Treatment Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bayer AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Neuralgia Treatment Market Other Major And Innovative Companies

    31.1. Novartis AG

    31.2. Bristol-Myers Squibb Company

    31.3. AstraZeneca plc

    31.4. Abbott Laboratories

    31.5. GlaxoSmithKline plc

    31.6. Eli Lilly and Company

    31.7. Gilead Sciences Inc.

    31.8. Teva Pharmaceutical Industries Ltd.

    31.9. Mylan N.V.

    31.10. Astellas Pharma Inc.

    31.11. Biogen Inc.

    31.12. Daiichi Sankyo Company Limited

    31.13. Boehringer Ingelheim International GmbH  

    31.14. Sun Pharmaceutical Industries Limited

    31.15. Horizon Therapeutics

    32. Global Neuralgia Treatment Market Competitive Benchmarking

    33. Global Neuralgia Treatment Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Neuralgia Treatment Market

    35. Neuralgia Treatment Market Future Outlook and Potential Analysis

    35.1 Neuralgia Treatment Market In 2028 - Countries Offering Most New Opportunities

    35.2 Neuralgia Treatment Market In 2028 - Segments Offering Most New Opportunities

    35.3 Neuralgia Treatment Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Neuralgia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Neuralgia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson & Johnson Financial Performance
  • Table 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance
  • Table 79: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Neuralgia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Neuralgia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson & Johnson Financial Performance
  • Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
  • Figure 79: Bayer AG Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Generic Central Nervous System Drugs Global Market Report 2024 – By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other Types), By Drug Classification (Branded Drugs, Generic Drugs), By Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation, Other Route Of Administrations), By Mode Of Purchase (Over-the-counter drugs, Prescription-Based Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Nerve Repair And Regenerative Global Market Report 2024 – By Product (Biomaterials, Neurostimulation And Neuromodulation Devices), By Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation And Neuromodulation Surgeries, Other Applications), By End-Users (Hospitals And Clinics, Ambulatory Surgical Centers (ASCs), Research And Academic Institutions, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Central Nervous System Biomarkers Global Market Report 2024 – By Type (Safety Biomarker, Efficacy Biomarker, Validation Biomarker, Other Types), By Disease (Multiple Sclerosis, Alzheimer's Disease, Parkinson's Disease, Traumatic Brain Injury, Other Diseases), By Application (Drug Discovery And Development, Personalized Medicines, Disease Risk Assessment, Diagnostics, Other Applications), By End-Users (Diagnostic Labs, Clinics, Hospitals, Research Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Brain And Neuroimaging Devices Global Market Report 2024 – By Imaging Type (Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Other Imaging Types), By Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Other Applications), By End-user (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Interventional Neurology Devices And Equipment Global Market Report 2024 – By Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices), Aneurysm Coiling & Embolization Devices By Type (Embolic coils, Flow diversion devices, Liquid embolic devices), Angioplasty Devices by Type (Carotid artery stents, Embolic protection systems), Support Devices By Type, Micro guide wires, Micro catheters), Neurothrombectomy Devices By Type (CLOT retrieval devices, Suction and aspiration devices, Snare), By End-User (Hospitals, Neurology clinics, Ambulatory care centers and others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurodegenerative Disorder Therapeutics Global Market Report 2024 – By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurophysiology Devices And Equipment Global Market Report 2024 – By Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECoG), Evoked potential (EP)), By Modality (Standalone, Portable), By End Users (Hospitals, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurostimulation Devices Global Market Report 2024 – By Product (Implantable Devices, External Devices), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), By End User (Hospitals, Rehabilitation Centers, Medical Clinic) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the neuralgia treatment market?

Neuralgia treatment refers to treating a medical condition characterized by chronic pain that affects the nerves and can be caused by injury, infection, or underlying medical conditions. Neuralgia treatment is used to manage symptoms, slow the progression of the Neuralgia and prevent complications. request a sample here

How will the neuralgia treatment market drivers and restraints affect the neuralgia treatment market dynamics? What forces will shape the neuralgia treatment industry going forward?

The neuralgia treatment market major growth driver - Growing Prevalence Of Chronic Diseases, Including Diabetes, Fuels Growth In The Neuralgia Treatment Market. request a sample here

What is the forecast market size or the forecast market value of the neuralgia treatment market?

The neuralgia treatment market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.3 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising prevalence of neuralgia, neuropathic pain awareness, rise in chronic pain conditions, presence of high disposable income, government initiatives. The neuralgia treatment market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to aging population, emerging therapies, increasing incidences of diabetes, high healthcare expenditure. Major trends in the forecast period include advancements in pain management, innovative products, digital health integration, development of new drug delivery systems. request a sample here

How is the neuralgia treatment market segmented?

The neuralgia treatment market is segmented
1) By Treatment: Drug Based, Surgeries
2) By Indication: Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia
3) By Distribution channels: Drug Stores, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Use: Hospitals And Clinics, Ambulatory Surgery Centers, Other End-UsersFor further insights on the neuralgia treatment market request a sample here

Which region has the largest share of the neuralgia treatment market? What are the other regions covered in the report?

North America was the largest region in the neuralgia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuralgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the neuralgia treatment market?

Major players in the neuralgia treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Horizon Therapeutics, Purdue Pharma, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals, Glenmark Pharmaceuticals, Tonix Pharmaceuticals. request a sample here.

What are the key trends in the neuralgia treatment market?

Major trend in the neuralgia treatment market - Innovative Products Drive Market Advancements In The Neuralgia Treatment Industry. request a sample here.

What are the major opportunities in the neuralgia treatment market? What are the strategies for the neuralgia treatment market?

For detailed insights on the major opportunities and strategies in the neuralgia treatment market, request a sample here.

How does the neuralgia treatment market relate to the overall economy and other similar markets?

For detailed insights on neuralgia treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the neuralgia treatment industry?

For detailed insights on the mergers and acquisitions in the neuralgia treatment industry, request a sample here.

What are the key dynamics influencing the neuralgia treatment market growth? SWOT analysis of the neuralgia treatment market.

For detailed insights on the key dynamics influencing the neuralgia treatment market growth and SWOT analysis of the neuralgia treatment industry, request a sample here.